These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 8592985)

  • 1. Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure.
    Knox JR
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2593-601. PubMed ID: 8592985
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-lactamases and bacterial resistance to antibiotics.
    Frère JM
    Mol Microbiol; 1995 May; 16(3):385-95. PubMed ID: 7565100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHV-type beta-lactamases.
    Tzouvelekis LS; Bonomo RA
    Curr Pharm Des; 1999 Nov; 5(11):847-64. PubMed ID: 10539992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanisms of bacterial resistance to beta-lactams by beta-lactamases].
    Sawai T
    Nihon Rinsho; 1997 May; 55(5):1225-30. PubMed ID: 9155179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Energetic, structural, and antimicrobial analyses of beta-lactam side chain recognition by beta-lactamases.
    Caselli E; Powers RA; Blasczcak LC; Wu CY; Prati F; Shoichet BK
    Chem Biol; 2001 Jan; 8(1):17-31. PubMed ID: 11182316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics.
    Chaïbi EB; Sirot D; Paul G; Labia R
    J Antimicrob Chemother; 1999 Apr; 43(4):447-58. PubMed ID: 10350372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of antibiotic resistance and beta-lactamase inhibition by mechanism-based inactivators: perspectives and future directions.
    Therrien C; Levesque RC
    FEMS Microbiol Rev; 2000 Jul; 24(3):251-62. PubMed ID: 10841972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of extended-spectrum beta-lactamase Toho-1: insights into the molecular mechanism for catalytic reaction and substrate specificity expansion.
    Ibuka AS; Ishii Y; Galleni M; Ishiguro M; Yamaguchi K; Frère JM; Matsuzawa H; Sakai H
    Biochemistry; 2003 Sep; 42(36):10634-43. PubMed ID: 12962487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of naturally occurring extended-spectrum TEM beta-lactamase variants by fluctuating beta-lactam pressure.
    Blazquez J; Morosini MI; Negri MC; Baquero F
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2182-4. PubMed ID: 10898697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncovalent interaction energies in covalent complexes: TEM-1 beta-lactamase and beta-lactams.
    Wang X; Minasov G; Shoichet BK
    Proteins; 2002 Apr; 47(1):86-96. PubMed ID: 11870868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibiotics.
    Wang F; Cassidy C; Sacchettini JC
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2762-71. PubMed ID: 16870770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular evolution of bacterial beta-lactam resistance.
    Knox JR; Moews PC; Frere JM
    Chem Biol; 1996 Nov; 3(11):937-47. PubMed ID: 8939710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detrimental effect of the combination of R164S with G238S in TEM-1 beta-lactamase on the extended-spectrum activity conferred by each single mutation.
    Giakkoupi P; Tzelepi E; Tassios PT; Legakis NJ; Tzouvelekis LS
    J Antimicrob Chemother; 2000 Jan; 45(1):101-4. PubMed ID: 10629019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Appearance of extended-spectrum beta-lactamases].
    Iyobe S
    Nihon Rinsho; 1997 May; 55(5):1219-24. PubMed ID: 9155178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Beta-lactamases and their role in resistance. PART 2: beta-lactamases in 21st century].
    Bedenić B
    Lijec Vjesn; 2005; 127(1-2):12-21. PubMed ID: 16145868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-spectrum beta-lactamases: an actual problem of hospital microbiology (a review).
    Szabó D; Barcs I; Rozgonyi F
    Acta Microbiol Immunol Hung; 1997; 44(4):309-25. PubMed ID: 9554165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Reaction Mechanism of Metallo-β-Lactamases Is Tuned by the Conformation of an Active-Site Mobile Loop.
    Palacios AR; Mojica MF; Giannini E; Taracila MA; Bethel CR; Alzari PM; Otero LH; Klinke S; Llarrull LI; Bonomo RA; Vila AJ
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress toward inhibitors of metallo-β-lactamases.
    McGeary RP; Tan DT; Schenk G
    Future Med Chem; 2017 May; 9(7):673-691. PubMed ID: 28504895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics.
    Medeiros AA
    Clin Infect Dis; 1997 Jan; 24 Suppl 1():S19-45. PubMed ID: 8994778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-lactamases: molecular studies.
    Coulson A
    Biotechnol Genet Eng Rev; 1985; 3():219-53. PubMed ID: 3911975
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.